CDR-Life has formed a successful partnership with Boehringer Ingelheim bringing together its antibody fragment expertise with Boehringer’s clinical development and marketing expertise.
We are open to partnering with companies, academic collaborators, and individuals who share our vision and can help bring our innovations to patients.
Our team has a substantial track record in forming and working in partnerships between pharma and biotech companies to bring new therapeutics into patients and onto the market.
«Partnering with CDR-Life provides Boehringer Ingelheim with the opportunity to collaborate with a team that has a proven track record developing antibody fragment-based therapeutics…»
Clive R. Wood, Ph.D., Corporate Senior Vice President and Global Head of Discovery Research, Boehringer Ingelheim
Contact us for partnering opportunities.
AACR 2022, April 8-12 in New Orleans, LA
ASCO 2022, June 3-7 in Chicago, IL
BIO International Convention, June 13-16 in San Diego, CA